KLEMP WALTER V Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$340,806.89
Insider Sells Quantity
1
Insider Sells Sum
$340,600.00

Insider Activity of KLEMP WALTER V

According to the SEC Form 4 filings, KLEMP WALTER V, being in a position of

  1. CEO and President at Moleculin Biotech, Inc.,
    оver the last 12 months, has bought 533333 shares for $400,000, and sold 0 shares,
    over all time since 2017-05-11, has bought 1598867 shares for $990,806, and sold 200000 shares for $340,600.

Biography of KLEMP WALTER V

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $400,0001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-08-03PurchaseMoleculin Biotech, Inc.
MBRX
CEO and President
533,333
22.8193%
$0.75$400,000+22.82%
2025-06-23PurchaseMoleculin Biotech, Inc.
MBRX
CEO and President
675,675
6.4607%
$0.37$250,000-31.68%
2023-12-26PurchaseMoleculin Biotech, Inc.
MBRX
CEO and President
188,404
0.6709%
$0.69$129,999-59.21%
2022-11-25PurchaseMoleculin Biotech, Inc.
MBRX
CEO and President
45,000
0.1562%
$1.28$57,632-49.25%
2022-11-21PurchaseMoleculin Biotech, Inc.
MBRX
CEO and President
22,500
0.0729%
$1.15$25,866-46.83%
2022-11-17PurchaseMoleculin Biotech, Inc.
MBRX
CEO and President
24,742
0.0849%
$1.02$25,257-36.28%
2022-11-16PurchaseMoleculin Biotech, Inc.
MBRX
CEO and President
85,213
0.2832%
$0.97$82,614-34.97%
2017-08-16SaleMoleculin Biotech, Inc.
MBRX
Chief Executive Officer
200,000
0.6259%
$1.70$340,600-30.57%
2017-05-11PurchaseMoleculin Biotech, Inc.
MBRX
Chief Executive Officer
24,000
0.133%
$0.81$19,440+128.51%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.